Clinical Trials in Tennessee

Showing 13921-13940 of 20,239 trials

Pivotal Study to Evaluate the Effectiveness of a Micro-coring Device Treating Moderate to Severe Facial Wrinkles

NCT03573271

Study evaluating the effectiveness of a micro-coring device for the treatment of moderate to severe cheek wrinkles.

Cytrellis Biosystems, Inc.20 participantsStarted Mar 2018

Sacramento, California, United States • Miami, Florida, United States • New York, New York, United States +2 more locations

COMPLETEDPhase 340 miles

Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris

NCT01880320

The study hypothesis are based on the assumption that : * CD0271 0.3%/CD1579 2.5% Gel provides superior clinical efficacy compared with Topical Gel Vehicle in the overall population and in the subgroup of severe Subjects * CD0271 0.3%/CD1579 2.5% Gel applied once daily for up to 12 weeks has an acceptable safety and tolerability profile

Acne Vulgaris

Galderma R&D503 participantsStarted Jul 2013

Birmingham, Alabama, United States • Mobile, Alabama, United States • Hot Springs, Arkansas, United States +28 more locations

Pivotal Study to Evaluate the Effectiveness of a Micro-coring Device Treating Moderate to Severe Facial Wrinkles

Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris

Find Trials by Condition in Tennessee

An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate

COOL-ARREST Pilot Study to Assess Intravascular Temperature Management (IVTM) in the Treatment of Cardiac Arrest

Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis)

Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas

Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis

ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel

A Direct-to-patient Intervention to Increase Rates of Osteoporosis Care

Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America

A Post-approval LAP-BAND® Lower Body Mass Index (LBMI) Study

Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry

VenaSeal Sapheon Closure System Pivotal Study (VeClose)

Innovative Tool to Increase Completion of Human Papillomavirus (HPV) Vaccine Series

Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma

Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets